Skip to main content
Keeps Biopharma Inc. logo

Keeps Biopharma Inc. — Investor Relations & Filings

Ticker · 256940 ISIN · KR7256940008 KO Manufacturing
Open in API
Filings indexed 290 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 256940

About Keeps Biopharma Inc.

http://kpscorp.co.kr/

Keeps Biopharma Inc. is a company with operations in both manufacturing and biopharmaceuticals. Its manufacturing activities include the production of equipment for semiconductors and flat panel displays, such as organic light-emitting diodes (OLEDs), as well as cleanroom consumables. Concurrently, the company is expanding its biopharmaceutical business through research and development. Its strategic focus is on building a therapeutic pipeline centered on oncology and metabolic diseases, which includes the development of novel anticancer drugs and combination therapies.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) covering the period January 1, 2026 to March 31, 2026, includes full financial statements, notes, management’s analysis, auditor’s opinion, and company overview. This matches the definition of an Interim / Quarterly Report with actual financial data rather than just an announcement or summary. Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 94% confidence The document is a ‘주식등의 대량보유상황보고서’ (Large Shareholding Report) filed under Korea’s Capital Markets Act, detailing an existing major shareholder’s holdings, changes in share counts, related parties, and reporting periods. It is not simply an announcement of a report or a company share buyback; rather, it is the actual report of a significant share ownership notification. This matches the “Major Shareholding Notification” category (MRQ).
2026-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서” filed to the FSC and KRX, detailing an executive’s share ownership and a disposal transaction (248,385 shares). This matches an insider share transaction report by a director. Therefore, it is classified as Director’s Dealing (insider transaction).
2026-05-14 Korean
본점소재지변경
Regulatory Filings Classification · 85% confidence The document is an official announcement of a change in the company’s head office address (“본점소재지변경”). This is a corporate action notice that does not match any more specific category (e.g., not a financial report, dividend notice, board change, or share issue). Therefore it falls into the fallback “Regulatory Filings” category (RNS).
2026-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is the official results announcement of resolutions passed at the regular shareholders’ meeting, listing vote outcomes, approval percentages, and detailed agenda items (e.g., financial statement approval, director elections). This matches Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-03-31 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for (주)킵스바이오파마, covering the fiscal years 2024 and 2025. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. This is a formal, full-year financial audit report, which falls under the 'Audit Report / Information' category. FY 2025
2026-03-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.